Sarepta (SRPT) PT Raised to $76 at Oppenheimer Amid Eteplirsen Approval
Go back to Sarepta (SRPT) PT Raised to $76 at Oppenheimer Amid Eteplirsen ApprovalSAREPTA THERAP (NASDAQ: SRPT) | Delayed: 116.96 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $116.96 | 52 Week High | $63.73 | |||
Open | $116.96 | 52 Week Low | $8.00 | |||
Day High | $116.96 | P/E | N/A | |||
Day Low | $116.96 | EPS | $-5.69 | |||
Volume | 891 |